enGene Therapeutics (ENGN) Interest & Investment Income (2023 - 2026)
enGene Therapeutics (ENGN) posted Interest & Investment Income of $2.4 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 7.5% from $2.23 million a year earlier but down 9.8% from the prior quarter.
enGene Therapeutics (ENGN) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Interest & Investment Income at enGene Therapeutics was $9.78 million, down 6.6% year-over-year; for FY2025 (ended Oct 31, 2025), it was $9.43 million, down 9.5% from FY2024.
- Annual Interest & Investment Income shows a three-year compound annual growth rate of 318.1% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Interest & Investment Income was $10.41 million in FY2024 (+832.2%), $1.12 million in FY2023 (+765.9%) and $129,000 in FY2022.
- Quarterly Interest & Investment Income has run from a low of $149,000 in fiscal Q2 2023 to a high of $3.38 million in fiscal Q3 2024 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 92.4% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q3 2024, with growth of 757.9%; the weakest was fiscal Q4 2025, with a decline of 34.7%.
- According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $2.66 million (Q2 2026), $2.74 million (Q1 2026) and $1.98 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | enGene Therapeutics | 130.01 Mn | 130.01 Mn | - | 2.40 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2.40 Mn |
| Apr 30, 2026 | 2.66 Mn |
| Jan 31, 2026 | 2.74 Mn |
| Oct 31, 2025 | 1.98 Mn |
| Jul 31, 2025 | 2.23 Mn |
| Apr 30, 2025 | 2.49 Mn |
| Jan 31, 2025 | 2.73 Mn |
| Oct 31, 2024 | 3.02 Mn |
| Jul 31, 2024 | 3.38 Mn |
| Apr 30, 2024 | 2.98 Mn |
| Jan 31, 2024 | 1.03 Mn |
| Oct 31, 2023 | 407,000.00 |
| Jul 31, 2023 | 394,000.00 |
| Apr 30, 2023 | 149,000.00 |
| Jan 31, 2023 | 167,000.00 |
enGene Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();